PALO ALTO, Calif., Dec. 11, 2018 /PRNewswire/ -- Varian (NYSE:
VAR) today announced the Paul Scherrer Institute (PSI) Center for
Proton Therapy in Switzerland has
begun utilizing Varian's Eclipse treatment planning system for
intensity modulated proton therapy (IMPT) treatments. Additionally,
the center is now employing Varian's ARIA oncology information
management software. The Eclipse treatment planning software
creates an optimized treatment plan based on a physician's dose
instructions, and information about the size, shape, and location
of the tumor to be treated with proton therapy.
PSI delivered its first patient treatments in July 2018 based on plans developed in the Eclipse
system. The IMPT treatment was delivered on a Varian ProBeam
gantry, with the treatment team utilizing ProBeam's full
remote-control capabilities from the treatment control room to
manage both gantry and table motion.
"Over the past 34 years, PSI has treated over 8,500 patients
with proton therapy, and we have recently expanded our capacity
through a joint project with the University Hospital Zurich and the
University of Zurich," said Prof.
Damien C. Weber, chairman of the
Center for Proton Therapy, PSI. "The Eclipse and ARIA solutions
have played an important role in this collaboration across
institutions and ensuring each patient receives a personally
tailored treatment plan."
"PSI has been a leading innovator in the field of IMPT and our
main development partner for more than a decade," said Kolleen Kennedy, chief growth officer and
president of Varian's Proton Therapy Solutions. "We are proud
to see that many of the innovations from PSI's first IMPT system
have been incorporated into the ProBeam and Eclipse systems."
ARIA is a comprehensive electronic medical record and image
management system that aggregates patient data into an organized,
oncology-specific medical chart with functional components for
managing clinical, administrative and financial operations for
medical, radiation and surgical oncology. The ARIA system provides
a seamless flow of information for managing the patient's entire
journey—from diagnosis through follow-up.
For more information on Varian's ProBeam system, visit
www.varian.com/probeam.
About Varian
Varian is a leader in developing and
delivering cancer care solutions and is focused on creating a world
without fear of cancer. Headquartered in Palo Alto, California, Varian employs
approximately 7,000 people around the world. For more
information, visit http://www.varian.com and follow @VarianMedSys
on Twitter.
Press Contact
Mark
Plungy
Director, Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/paul-scherrer-institute-utilizing-varian-software-solution-for-advanced-proton-therapy-treatments-300763079.html
SOURCE Varian